Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
El anticoagulante de uso y síntesis BIB-953 es otro nuevo fármaco anticoagulante oral aprobado por la Administración de Drogas y Alimentos de los EE. UU. después de la warfarina para prevenir accidentes cerebrovasculares y embolias en pacientes con fibrilación auricular no valvular. campo de la terapia anticoagulante y el campo de la prevención de trombosis potencialmente mortales, y es un hito.
PRODUCTOS POR GRUPO : Intermedios API > Intermedio para CAS 872728-81-9
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.